Doxycycline inhibits the progression of metastases in early-stage osteosarcoma by downregulating the expression of MMPs, VEGF and ezrin at primary sites

Mirabello, 2009, Osteosarcoma incidence and survival improvement, Cancer, 115, 1531, 10.1002/cncr.24121 Lindsey, 2017, Osteosarcoma Overview. Rheumatol Ther., 4, 25, 10.1007/s40744-016-0050-2 Durfee, 2016, Review of Osteosarcoma and Current Management, Rheumatol Ther, 3, 221, 10.1007/s40744-016-0046-y Bruland ØS, Høifødt H, Hall KS, Smeland S, Fodstad Ø. Bone marrow micrometastases studied by an immunomagnetic isolation procedure in extremity localized non-metastatic osteosarcoma patients. In: Jaffe N., Bruland O. BS, editor. Pediatric and Adolescent Osteosarcoma Cancer Treatment and Research [Internet]. Springer, Boston, MA; 2009. p. 509–15. Available from: https://pubmed.ncbi.nlm.nih.gov/20213412/. Huang, 2019, Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-based study, J Bone Oncol, 16 Nataraj, 2016, Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients, Clin Transl Oncol, 18, 937, 10.1007/s12094-015-1467-8 Zhang, 2018, Progress in the chemotherapeutic treatment of osteosarcoma, Oncol Lett, 16, 6228 Sleire L, Førde-Tislevoll HE, Netland IA, Leiss L, Skeie BS, Enger PØ. Drug repurposing in cancer. Pharmacol Res [Internet]. 2017;124:74–91. Available from: 10.1016/j.phrs.2017.07.013. Galván-Salazar, 2016, Preclinical trial on the use of doxycycline for the treatment of adenocarcinoma of the duodenum, Mol Clin Oncol, 5, 657, 10.3892/mco.2016.1013 Lin, 2018, Doxycycline targets aldehyde dehydrogenasepositive breast cancer stem cells, Oncol Rep, 39, 3041 Son, 2009, Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells, Anticancer Res, 29, 3995 Ali, 2017, Doxycycline as Potential Anti-cancer Agent, Anticancer Agents Med Chem, 17, 1617 Matsumoto, 2017, Doxycycline induces apoptosis via ER stress selectively to cells with a cancer stem cell-like properties: importance of stem cell plasticity, Oncogenesis., 6, 397, 10.1038/s41389-017-0009-3 Scatena, 2018, Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study, Front Oncol, 8, 452, 10.3389/fonc.2018.00452 Chen, 2015, Postoperative infection and survival in osteosarcoma patients: Reconsideration of immunotherapy for osteosarcoma, Mol Clin Oncol, 3, 495, 10.3892/mco.2015.528 Thabit, 2019, Antibiotic penetration into bone and joints: An updated review, Int J Infect Dis, 81, 128, 10.1016/j.ijid.2019.02.005 Czarnecka, 2020, Molecular Biology of Osteosarcoma, Cancers (Basel), 12, 2130, 10.3390/cancers12082130 Astolfi, 2020, Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile, Cancers (Basel), 12, 2126, 10.3390/cancers12082126 Rizzo, 2020, Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis, Cancers (Basel), 12, 1899, 10.3390/cancers12071899 Cakir, 1999, Direct action by doxycycline against canine osteosarcoma cell proliferation and collagenase (MMP-1) activity in vitro, In Vivo (Brooklyn) [Internet], 13, 327 Fife, 1997, Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells, J Lab Clin Med, 130, 530, 10.1016/S0022-2143(97)90130-X Roomi, 2014, In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors, Int J Oncol, 44, 27, 10.3892/ijo.2013.2159 Lipowsky, 2011, Relative roles of doxycycline and cation chelation in endothelial glycan shedding and adhesion of leukocytes, Am J Physiol - Hear Circ Physiol, 300, 415, 10.1152/ajpheart.00923.2010 Siddhartha, 2021, Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions, Toxicol Appl Pharmacol, 426, 10.1016/j.taap.2021.115593 Quintero-Fabián, 2019, Role of Matrix Metalloproteinases in Angiogenesis and Cancer, Front Oncol, 9, 1 Tang, 2019, Pathological and therapeutic aspects of matrix metalloproteinases: Implications in osteosarcoma, Asia Pac J Clin Oncol, 15, 218, 10.1111/ajco.13165 Ebrahem Q, Chaurasia SS, Vasanji A, Qi JH, Klenotic PA, Cutler A, et al. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo. Am J Pathol [Internet]. 2010;176(1):496–503. Available from: http://dx.doi.org/10.2353/ajpath.2010.080642. Merentie, 2018, Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice, PLoS One, 13, 10.1371/journal.pone.0190981 Hurst, 2016, Targeting dormant micrometastases: Rationale, evidence to date and clinical implications, Ther Adv Med Oncol, 8, 126, 10.1177/1758834015624277 Tao, 2018, Adenovirus-mediated small interfering RNA targeting ezrin induces apoptosis and inhibits metastasis of human osteosarcoma MG-63 cells, Biosci Rep, 38, 10.1042/BSR20180351 Zhang, 2014, Osteosarcoma metastasis: prospective role of ezrin, Tumour Biol, 35, 5055, 10.1007/s13277-014-1799-y Tang, 2019, Inhibition of Ezrin suppresses cell migration and invasion in human nasopharyngeal carcinoma, Oncol Lett, 18, 553 Khan, 2020, Bidirectional Tumor-Promoting Activities of Macrophage Ezrin, Int J Mol Sci, 21, 7716, 10.3390/ijms21207716 Armakolas, 2015, Oncogenic role of the Ec peptide of the IGF-1Ec isoform in prostate cancer, Mol Med, 167, 10.2119/molmed.2014.00222 Liang, 2007, In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro, Nat Protoc, 2, 329, 10.1038/nprot.2007.30 Hong, 2015, Characterization of the metastatic phenotype of a panel of established osteosarcoma cells, Oncotarget, 6, 29469, 10.18632/oncotarget.5177 Lauvrak, 2013, Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes, Br J Cancer, 109, 2228, 10.1038/bjc.2013.549 Jacques, 2019, Murine Models of Bone Sarcomas, Methods Mol Biol, 1914, 331, 10.1007/978-1-4939-8997-3_18 Price, 2014, Spontaneous and experimental metastasis models: nude mice, Methods Mol Biol, 1070, 223, 10.1007/978-1-4614-8244-4_17 Yuan, 2009, Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases, Cancer Invest, 27, 435, 10.1080/07357900802491477 Luu, 2005, An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis, Clin Exp Metastasis, 22, 319, 10.1007/s10585-005-0365-9 Scott, 2016, Heterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior, DMM Dis Model Mech, 9, 1435 Uluçkan, 2015, Preclinical mouse models of osteosarcoma, Bonekey Rep, 4, 670, 10.1038/bonekey.2015.37 Tang, 2017, Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-ΚB activation, Mol Cancer, 16, 1, 10.1186/s12943-017-0607-x Gao, 2019, The improved antitumor efficacy of continuous intratumoral chemotherapy with cisplatin-loaded implants for the treatment of sarcoma 180 tumor-bearing mice, Drug Deliv, 26, 208, 10.1080/10717544.2019.1574938 He, 2022, Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy, Drug Deliv, 29, 478, 10.1080/10717544.2022.2032878 Hayata, 2013, Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice, PLoS One, 8, e53131, 10.1371/journal.pone.0053131 Fourman, 2018, Quantitative primary tumor indocyanine green measurements predict osteosarcoma metastatic lung burden in a mouse model, Clin Orthop Relat Res, 476, 479, 10.1007/s11999.0000000000000003 Jirkof, 2015, Buprenorphine for pain relief in mice: repeated injections vs sustained-release depot formulation, Lab Anim, 49, 177, 10.1177/0023677214562849 Yu, 2010, A humanized anti-VEGF rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models, PLoS One, 5, e9072, 10.1371/journal.pone.0009072 Fernandes-Alnemri, 1994, CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme, J Biol Chem, 269, 30761, 10.1016/S0021-9258(18)47344-9 Raimondi, 2017, Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment, Oncotarget, 8, 100831, 10.18632/oncotarget.19852 Jolly, 2019, E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms, Mol Cancer Res, 17, 1391, 10.1158/1541-7786.MCR-18-0763 Jong, 2000, Proliferative activity (ki-67 expression) and outcome in high grade osteosarcoma: a study of 27 cases, Sarcoma, 4, 47, 10.1155/S1357714X00000086 Ren, 2014, Role of ezrin in osteosarcoma metastasis, Adv Exp Med Biol, 804, 181, 10.1007/978-3-319-04843-7_10 Rastogi, 2012, Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study, Int Orthop, 36, 2315, 10.1007/s00264-012-1663-x Huang, 2018, Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances, Sensors (Basel), 18, 3249, 10.3390/s18103249 Lucchetti, 2019, Plasma and Brain Concentrations of Doxycycline after Single and Repeated Doses in Wild-Type and APP23 Mice, J Pharmacol Exp Ther, 368, 32, 10.1124/jpet.118.252064 Dickens, 2003, Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts, J Pediatr Hematol Oncol, 25, 709, 10.1097/00043426-200309000-00007 Fields, 2019, The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma, Cells, 8, 984, 10.3390/cells8090984 Sparano, 2004, Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196, J Clin Oncol, 22, 4683, 10.1200/JCO.2004.08.054 Evans, 2001, A phase II trial of marimastat in advanced pancreatic cancer, Br J Cancer, 85, 1865, 10.1054/bjoc.2001.2168 Bramhall, 2002, Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial, Br J Cancer, 86, 1864, 10.1038/sj.bjc.6600310 Rudek, 2001, Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer, J Clin Oncol, 19, 584, 10.1200/JCO.2001.19.2.584 Muz, 2015, The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy, Hypoxia (Auckl), 3, 83, 10.2147/HP.S93413 Mantadakis, 2001, Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma, J Pediatr Hematol Oncol, 23, 286, 10.1097/00043426-200106000-00010 Zhao, 2015, VEGF silencing inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via PI3K/AKT signaling pathway, Int J Clin Exp Med, 8, 12411 Klotzsche-von Ameln, 2013, PHD4 stimulates tumor angiogenesis in osteosarcoma cells via TGF-α, Mol Cancer Res, 11, 1337, 10.1158/1541-7786.MCR-13-0201 Altoé, 2021, Doxycycline Hyclate Modulates Antioxidant Defenses, Matrix Metalloproteinases, and COX-2 Activity Accelerating Skin Wound Healing by Secondary Intention in Rats, Oxid Med Cell Longev, 2021, 10.1155/2021/4681041 He, 2014, Doxycycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularization, J Biol Chem, 289, 8019, 10.1074/jbc.M113.535765 Dumars, 2016, Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma, Oncotarget, 7, 78343, 10.18632/oncotarget.13055 Hanafy, 2018, Tumor histopathological response to neoadjuvant chemotherapy in childhood solid malignancies: is it still impressive?, J Investig Med, 66, 289, 10.1136/jim-2017-000531 Basile, 2020, Prognostic Factors for Development of Subsequent Metastases in Localized Osteosarcoma: A Systematic Review and Identification of Literature Gaps, Sarcoma, 2020, 10.1155/2020/7431549 Sannino, 2017, Epithelial-to-Mesenchymal and Mesenchymal-to-Epithelial Transition in Mesenchymal Tumors: A Paradox in Sarcomas?, Cancer Res, 77, 4556, 10.1158/0008-5472.CAN-17-0032 Qin, 2015, Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells, Oncotarget, 6, 40667, 10.18632/oncotarget.5842 Thomas, 2022, Transcriptome profiling reveals that VNPP433-3β, the lead next-generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial-mesenchymal transition and stem cell markers, Mol Carcinog, 61, 643, 10.1002/mc.23406 Deryugina, 2015, Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature, Matrix Biol, 44-46, 94, 10.1016/j.matbio.2015.04.004 Li, 2015, Ki67 is a promising molecular target in the diagnosis of cancer (review), Mol Med Rep, 11, 1566, 10.3892/mmr.2014.2914 Khan, 2020, Bidirectional Tumor-Promoting Activities of Macrophage Ezrin, Int J Mol Sci, 21, 7716, 10.3390/ijms21207716 Zhang, 2014, Osteosarcoma metastasis: prospective role of ezrin, Tumour Biol, 35, 5055, 10.1007/s13277-014-1799-y PosthumaDeBoer, 2011, Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature, Clin Exp Metastasis, 28, 493, 10.1007/s10585-011-9384-x Cekanova, 2014, Animal models and therapeutic molecular targets of cancer: utility and limitations, Drug Des Devel Ther, 8, 1911, 10.2147/DDDT.S49584